Top 10 Companies in the Medical Polyglycolic Acid (PGA) Industry (2024): Market Leaders Advancing Biodegradable Medical Solutions

In Business Insights
June 09, 2025

The Global Medical Polyglycolic Acid (PGA) Market was valued at USD 1.15 Billion in 2023 and is projected to reach USD 1.95 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.00% during the forecast period (2024-2032). This growth is fueled by increasing demand for biodegradable medical implants, advancements in suture technology, and expanding applications in drug delivery systems.

As the healthcare sector shifts toward sustainable biomaterials with superior performance characteristics, PGA has emerged as a critical material for medical applications due to its excellent biocompatibility and predictable degradation profile. In this blog, we examine the Top 10 Companies in the Medical Polyglycolic Acid (PGA) Industry—innovators who are driving material science breakthroughs and commercialization of next-gen medical devices.


🔟 1. Sinopec

Headquarters: Beijing, China
Key Offering: PGA resins for medical applications

Sinopec is China’s largest integrated energy and chemical company with growing capabilities in high-performance polymers. Its PGA production facilities leverage proprietary polymerization technologies to meet stringent medical-grade standards.

Innovation Highlights:

  • Patented synthesis methods for ultra-pure PGA
  • Strategic partnerships with medical device manufacturers
  • Vertical integration from raw materials to finished polymers

Download FREE Sample Report:
Medical Polyglycolic Acid (PGA) Market – View in Detailed Research Report


9️⃣ 2. Shanghai Pujing Chemical

Headquarters: Shanghai, China
Key Offering: Medical-grade PGA resins and compounds

A specialist in high-performance biomaterials, Shanghai Pujing Chemical has developed PGA formulations with tailored degradation rates for different clinical applications. The company maintains GMP-certified production facilities for medical polymers.

Innovation Highlights:

  • Custom degradation profiles (3-6 months)
  • Reinforced PGA composites for orthopedic applications
  • Established supply chains across Asia-Pacific markets

8️⃣ 3. Yulin Energy Group

Key Offering: PGA raw materials and glycolide monomers

The company has become a major supplier to global medical device manufacturers through strategic expansion of its glycolide monomer production capacity.

Innovation Highlights:

  • Large-scale polymerization capabilities meeting pharmaceutical standards
  • Closed-loop production system minimizing environmental impact
  • Technical support services for medical-grade polymer applications

7️⃣ 4. Danhua Technology

Headquarters: Hangzhou, China
Key Offering: Specialty PGA formulations

Danhua Technology specializes in developing modified PGA variants with enhanced mechanical properties for demanding medical applications.

Innovation Highlights:

  • Impact-modified PGA for load-bearing implants
  • Co-polymer blends with extended degradation profiles
  • ISO 13485 certified manufacturing processes

Download FREE Sample Report:
Medical Polyglycolic Acid (PGA) Market – View in Detailed Research Report


6️⃣ 5. Huayang Medical

Headquarters: Shenzhen, China
Key Offering: PGA-based implantable medical devices

Huayang Medical combines PGA material expertise with medical device engineering to create innovative resorbable solutions.

Innovation Highlights:

  • Thin-film PGA meshes for hernia repair
  • Antimicrobial PGA formulations through proprietary additive technology
  • Sterilization-compatible polymer blends

5️⃣ 6. Shenzhen Polymtek Biomaterial

Headquarters: Shenzhen, China
Key Offering: PGA fibers for surgical applications

Specializing in PGA fiber technologies, Polymtek supplies medical-grade sutures and scaffolds to global healthcare providers.

Innovation Highlights:

  • Continuous multifilament yarn production
  • Custom braided and monofilament suture configurations
  • 3D-printable PGA fiber matrices

4️⃣ 7. Kureha Corporation

Headquarters: Tokyo, Japan
Key Offering: High-purity PGA resins

Kureha brings decades of polymer expertise to medical applications, producing PGA with exceptionally low residual monomer content.

Innovation Highlights:

  • Pharmaceutical-grade purity standards
  • Controlled crystallization PGA formulations
  • Global regulatory compliance including FDA submissions

3️⃣ 8. Evonik Industries

Headquarters: Essen, Germany
Key Offering: Resomer® PGA polymers

Evonik’s health care business provides sophisticated PGA solutions under its Resomer® brand portfolio worldwide.

Innovation Highlights:

  • Customized degradation rate copolymers
  • Drug-eluting PGA matrices for controlled release applications
  • Technical support for medical device development

2️⃣ 9. Teleflex Incorporated

Headquarters: Wayne, Pennsylvania, USA
Key Offering: PGA-enhanced surgical products

Teleflex incorporates PGA in its portfolio of single-use surgical devices, applying advanced material engineering to clinical applications.

Innovation Highlights:

  • PGA-reinforced surgical staple lines
  • Composite PGA/PLA materials for optimal strength/degradation balance
  • High-volume medical device manufacturing expertise

Download FREE Sample Report:
Medical Polyglycolic Acid (PGA) Market – View in Detailed Research Report


1️⃣ 10. Corbion

Headquarters: Amsterdam, Netherlands
Key Offering: PURASORB® PGA polymers

Corbion is a global leader in biodegradable polymers, setting industry benchmarks for PGA performance in demanding medical environments.

Innovation Highlights:

  • Medical implant-grade PGA with consistent lot-to-lot performance
  • Sustainable production using renewable energy sources
  • Comprehensive technical and regulatory support services

Get Full Report Here:
Medical Polyglycolic Acid (PGA) Market – View in Detailed Research Report


🏥 Outlook: The Future of Medical PGA Is Smart and Specialized

The medical PGA market is evolving beyond basic sutures to enable sophisticated temporary medical implants and drug delivery systems. Material innovations and processing advancements are expanding PGA’s clinical applications while maintaining its core biocompatibility advantages.

📈 Key Trends Shaping the Market:

  • Development of PGA copolymers with tunable degradation rates
  • Integration of PGA in combination medical products
  • Advanced processing techniques for complex PGA device geometries
  • Growing adoption in minimally invasive surgical procedures

Get Full Report Here:
Medical Polyglycolic Acid (PGA) Market – View in Detailed Research Report

The companies profiled above are not only supplying PGA materials—they’re enabling transformative medical technologies through advanced biomaterial solutions.